title: Biomarkers for anti-angiogenic therapy in cancer.
abstract: Angiogenesis, the development of new vessels from existing vasculature, plays a central role in tumor growth, survival, and progression. On the molecular level it is controlled by a number of pro- and anti-angiogenic cytokines, among which the vascular endothelial growth factors (VEGFs), together with their related VEGF-receptors, have an exceptional position. Therefore, the blockade of VEGF signaling in order to inhibit angiogenesis was deemed an attractive approach for cancer therapy and drugs interfering with the VEGF-ligands, the VEGF receptors, and the intracellular VEGF-mediated signal transduction were developed. Although promising in pre-clinical trials, VEGF-inhibition proved to be problematic in the clinical context. One major drawback was the generally high variability in patient response to anti-angiogenic drugs and the rapid development of therapy resistance, so that, in total, only moderate effects on progression-free and overall survival were observed. Biomarkers predicting the response to VEGF-inhibition might attenuate this problem and help to further individualize drug and dosage determination. Although up to now no definitive biomarker has been identified for this purpose, several candidates are currently under investigation. This review aims to give an overview of the recent developments in this field, focusing on the most prevalent tumor species.
authors: Clinic for Plastic, Aesthetic and Hand Surgery, Otto-von-Guericke-University Magdeburg, Leipziger Str. 44, Magdeburg D-39120, Germany. daniela.grimm@farm.au.dk.
authors: Markus
authors: M
authors: Wehland
authors: Johann
authors: J
authors: Bauer
authors: Nils E
authors: NE
authors: Magnusson
authors: Manfred
authors: M
authors: Infanger
authors: Daniela
authors: D
authors: Grimm
mesh_terms: D020533:Angiogenesis Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D000818:Animals; D014408:Biomarkers, Tumor / Q000378:metabolism*; D006801:Humans; D008954:Models, Biological; D009369:Neoplasms / Q000098:blood supply* / Q000188:drug therapy* / Q000235:genetics; D009389:Neovascularization, Pathologic / Q000188:drug therapy*
chemical_list: D020533:Angiogenesis Inhibitors; D014408:Biomarkers, Tumor
references: Cancer. 1997 Feb 1;79(3):564-73
references: 9028369
references: Circ Res. 2008 Mar 28;102(6):637-52
references: 18369162
references: Thyroid. 2008 Mar;18(3):317-23
references: 17985985
references: J Endocrinol Invest. 2012 Feb;35(2):181-90
references: 21422803
references: Proc Natl Acad Sci U S A. 2012 Feb 7;109(6):E353-9
references: 22203991
references: Int J Mol Sci. 2013 Jan 09;14(1):1164-78
references: 23303277
references: Ann Oncol. 2009 Feb;20(2):227-30
references: 18842611
references: Clin Cancer Res. 2007 Dec 15;13(24):7388-93
references: 18094421
references: Oncologist. 2013;18(3):273-80
references: 23485622
references: J Vasc Res. 2005 May-Jun;42(3):202-13
references: 15832056
references: J Clin Oncol. 2010 Aug 1;28(22):3617-22
references: 20606091
references: Clin Sci (Lond). 2005 Sep;109(3):227-41
references: 16104843
references: Tissue Eng Part A. 2010 May;16(5):1559-73
references: 20001221
references: J Biol Chem. 1998 May 22;273(21):13313-6
references: 9582377
references: N Engl J Med. 2006 Dec 14;355(24):2542-50
references: 17167137
references: N Engl J Med. 2004 Jun 3;350(23):2335-42
references: 15175435
references: Biol Reprod. 2001 Apr;64(4):1033-40
references: 11259247
references: Expert Opin Pharmacother. 2012 Jun;13(9):1323-36
references: 22607009
references: J Clin Oncol. 2010 Feb 10;28(5):767-72
references: 20065189
references: Lancet. 2007 Dec 22;370(9605):2103-11
references: 18156031
references: Clin Cancer Res. 2005 May 15;11(10):3714-21
references: 15897568
references: FASEB J. 2012 Dec;26(12):5124-40
references: 22964303
references: J Clin Oncol. 2010 Jul 10;28(20):3239-47
references: 20498403
references: Am J Clin Pathol. 2010 Dec;134(6):873-9
references: 21088149
references: Nat Rev Mol Cell Biol. 2006 May;7(5):359-71
references: 16633338
references: Proc Natl Acad Sci U S A. 1998 Aug 4;95(16):9349-54
references: 9689083
references: Cancer. 2008 Apr 1;112(7):1471-9
references: 18260086
references: Expert Rev Proteomics. 2011 Feb;8(1):13-27
references: 21329425
references: CA Cancer J Clin. 2009 Jul-Aug;59(4):225-49
references: 19474385
references: Cell. 1996 Aug 9;86(3):353-64
references: 8756718
references: Cancer Metastasis Rev. 2008 Sep;27(3):363-74
references: 18506399
references: J Biol Chem. 1994 Oct 14;269(41):25646-54
references: 7929268
references: Cardiovasc Res. 2005 Feb 15;65(3):550-63
references: 15664381
references: Ann Oncol. 2012 Jan;23(1):46-52
references: 21464158
references: Breast Cancer Res Treat. 2006 Nov;100(2):229-35
references: 16932852
references: Cancer Res. 2002 Dec 1;62(23):6808-11
references: 12460889
references: J Clin Oncol. 2010 Jul 1;28(19):3191-8
references: 20516443
references: Endocrinology. 2004 Mar;145(3):1031-8
references: 14607854
references: Nature. 2007 Jan 4;445(7123):111-5
references: 17122771
references: J Clin Oncol. 2008 Apr 10;26(11):1810-6
references: 18347007
references: Tissue Eng Part A. 2009 Aug;15(8):2267-75
references: 19226201
references: J Cell Physiol. 2010 Sep;224(3):612-9
references: 20578236
references: Biochem Pharmacol. 2002 Sep;64(5-6):993-8
references: 12213597
references: Breast Cancer Res. 2000;2(2):125-32
references: 11250702
references: Clin Cancer Res. 2006 Sep 1;12(17):5018-22
references: 16951216
references: J Clin Oncol. 2012 Jan 1;30(1):34-41
references: 22124101
references: Nat Cell Biol. 2011 Sep 11;13(10):1202-13
references: 21909098
references: Clin Cancer Res. 2009 Dec 15;15(24):7652-7657
references: 19996223
references: Crit Rev Oncol Hematol. 2007 Jun;62(3):179-213
references: 17324579
references: Hum Mol Genet. 2012 Jan 15;21(2):456-62
references: 22010048
references: Clin Endocrinol (Oxf). 2013 May;78(5):760-7
references: 23009688
references: J Clin Endocrinol Metab. 2012 Aug;97(8):2754-63
references: 22639291
references: Genes Cancer. 2010 Feb 1;1(2):152-163
references: 20871783
references: Breast Cancer Res. 2012 Aug 20;14(4):R120
references: 22906178
references: Br J Cancer. 2011 Feb 15;104(4):599-604
references: 21304526
references: Nat Rev Cancer. 2008 Aug;8(8):592-603
references: 18650835
references: J Clin Oncol. 2004 Jun 1;22(11):2184-91
references: 15169807
references: N Engl J Med. 2007 Dec 27;357(26):2666-76
references: 18160686
references: Eur J Endocrinol. 2012 Nov;167(5):643-50
references: 22918300
references: Int J Colorectal Dis. 2012 Jun;27(6):715-20
references: 22139032
references: Ann Oncol. 2010 Sep;21(9):1804-1809
references: 20150572
references: J Clin Oncol. 2007 Oct 20;25(30):4743-50
references: 17909199
references: Cancer Chemother Pharmacol. 2011 Nov;68(5):1207-13
references: 21409384
references: Nat Med. 1997 Nov;3(11):1222-7
references: 9359696
references: Presse Med. 2012 Oct;41(10):917-26
references: 22281391
references: Cardiovasc Pathol. 2007 Sep-Oct;16(5):291-9
references: 17868880
references: Anticancer Res. 2011 Oct;31(10):3433-40
references: 21965758
references: Rev Med Liege. 2012 Jul-Aug;67(7-8):437-42
references: 22984765
references: Int J Cancer. 2010 Dec 15;127(12):2893-917
references: 21351269
references: Thyroid. 2013 Jan;23(1):58-63
references: 22973946
references: Nat Rev Mol Cell Biol. 2011 Aug 23;12(9):551-64
references: 21860391
references: Asian Pac J Cancer Prev. 2012;13(3):1059-63
references: 22631638
references: Cancer Metastasis Rev. 2007 Jun;26(2):319-31
references: 17458507
references: J Korean Med Sci. 2012 Sep;27(9):1014-8
references: 22969246
references: Lancet Oncol. 2011 Nov;12(12):1143-50
references: 22015057
references: Oncogene. 1990 Apr;5(4):519-24
references: 2158038
references: Br J Cancer. 2010 Oct 26;103(9):1407-14
references: 20924372
references: Lancet Oncol. 2012 Aug;13(8):827-37
references: 22759480
references: Nat Genet. 2011 Jan;43(1):60-5
references: 21131975
references: Biomed Pharmacother. 2000 Jul;54(6):322-6
references: 10989966
references: Mol Cell Endocrinol. 1999 Mar 25;149(1-2):29-40
references: 10375015
references: J Clin Oncol. 2008 Oct 10;26(29):4708-13
references: 18541897
references: J Clin Endocrinol Metab. 2010 Jun;95(6):2588-95
references: 20392874
references: J Clin Oncol. 2009 Apr 1;27(10):1675-84
references: 19255327
references: J Clin Oncol. 2013 Mar 20;31(9):1219-30
references: 23401453
references: Curr Med Chem. 2011;18(2):176-90
references: 21110808
references: Eur J Cancer. 2008 May;44(7):946-53
references: 18396036
references: Pharmacol Ther. 1991 Dec;52(3):407-22
references: 1726477
references: Urol Oncol. 2006 Nov-Dec;24(6):538-51
references: 17138135
references: J Clin Oncol. 2006 Jan 10;24(2):217-27
references: 16365183
references: Clin Cancer Res. 2011 Apr 1;17(7):2044-54
references: 21325074
references: Ann Oncol. 2010 Dec;21(12):2382-2389
references: 20497963
references: Endocr Rev. 1997 Feb;18(1):4-25
references: 9034784
references: Apoptosis. 2006 May;11(5):749-64
references: 16528471
references: Proteomics. 2012 Aug;12(15-16):2539-46
references: 22707460
references: Nat Med. 1995 Jan;1(1):27-31
references: 7584949
references: Curr Pharm Des. 2012;18(27):4244-57
references: 22632607
references: Nat Cell Biol. 2002 Jan;4(1):E2-5
references: 11780131
references: Oncogene. 1991 Sep;6(9):1677-83
references: 1656371
references: J Clin Endocrinol Metab. 2006 Aug;91(8):2892-9
references: 16684830
references: Anticancer Res. 2011 Sep;31(9):3007-18
references: 21868552
references: Lancet Oncol. 2010 Dec;11(12):1172-83
references: 21126687
references: Ann Oncol. 2007 Mar;18(3):581-92
references: 17287242
references: J Clin Oncol. 2010 Jan 20;28(3):453-9
references: 20008624
references: Cancer Chemother Pharmacol. 2011 Sep;68(3):763-8
references: 21170650
references: J Clin Oncol. 2012 May 1;30(13):1534-40
references: 22454414
references: Endocr Rev. 2004 Aug;25(4):581-611
references: 15294883
references: J Mol Med (Berl). 2000;78(2):102-10
references: 10794546
references: N Engl J Med. 1971 Nov 18;285(21):1182-6
references: 4938153
references: Am J Pathol. 1999 May;154(5):1381-90
references: 10329591
references: J Proteomics. 2010 Sep 10;73(10):1896-906
references: 20394844
references: J Clin Oncol. 2011 Nov 10;29(32):4286-93
references: 21990397
references: Mod Pathol. 2010 Aug;23(8):1052-60
references: 20473281
references: Proteomics. 2010 Mar;10(5):904-13
references: 20049858
references: Int J Cancer. 2002 Jan 20;97(3):393-9
references: 11774295
references: Nat Med. 2003 Jun;9(6):669-76
references: 12778165
references: J Transl Med. 2007 Jul 02;5:32
references: 17605814
references: Clin Cancer Res. 2009 May 15;15(10):3583-90
references: 19417018
references: Clin Cancer Res. 2008 Dec 1;14(23):7871-7
references: 19047116
references: Kidney Int. 2010 May;77(9):809-15
references: 20147887
references: J Clin Oncol. 2008 Oct 1;26(28):4672-8
references: 18824714
references: Thyroid. 2007 Jul;17(7):663-70
references: 17696837
references: N Engl J Med. 2008 Jul 3;359(1):31-42
references: 18596272
references: Nat Med. 1999 May;5(5):495-502
references: 10229225
references: Proteomics. 2011 May;11(10):2095-104
references: 21520503
references: Nature. 2007 Jan 4;445(7123):106-10
references: 17122772
references: J Clin Oncol. 2003 Jan 1;21(1):60-5
references: 12506171
references: J Clin Oncol. 2010 May 1;28(13):2137-43
references: 20368558
references: Urology. 2010 Oct;76(4):923-6
references: 20646741
references: J Clin Endocrinol Metab. 2010 Nov;95(11):5018-27
references: 20739388
references: Control Clin Trials. 2001 Oct;22(5):485-502
references: 11578783
references: Am J Physiol Cell Physiol. 2001 Jun;280(6):C1358-66
references: 11350730
references: Cancer. 2011 Sep 1;117(17):4026-32
references: 21858803
references: Cancer Res. 2006 Apr 1;66(7):3381-5
references: 16585157
references: J Exp Med. 2012 Jul 2;209(7):1289-307
references: 22711876
references: Cytokine. 2006 Dec;36(5-6):291-5
references: 17374490
references: Cancer Res. 2010 Feb 1;70(3):1063-71
references: 20103651
references: J Cancer Res Clin Oncol. 2012 Jul;138(7):1187-96
references: 22419441
references: Cancer. 2008 Jan 15;112(2):250-9
references: 18041064
references: J Clin Oncol. 2005 Jun 1;23(16):3697-705
references: 15738537
references: Ann Vasc Surg. 2008 Mar;22(2):273-84
references: 18346582
references: Clin Cancer Res. 2011 Feb 1;17(3):620-9
references: 21097692
references: Curr Genomics. 2011 Dec;12(8):626-31
references: 22654562
references: J Biol Chem. 1998 Nov 13;273(46):30336-43
references: 9804796
references: Nature. 2005 Dec 15;438(7070):946-53
references: 16355212
references: Am J Pathol. 2000 May;156(5):1499-504
references: 10793061
references: J Clin Oncol. 2011 Oct 20;29(30):3968-76
references: 21844504
references: Curr Mol Med. 2011 Jul;11(5):350-64
references: 21568935
references: J Biol Chem. 1993 May 15;268(14):10425-32
references: 7683678
references: J Clin Oncol. 2011 Apr 1;29(10):1252-60
references: 21383283
references: Nat Rev Drug Discov. 2004 May;3(5):391-400
references: 15136787
references: Curr Oncol Rep. 2011 Apr;13(2):97-102
references: 21222245
references: Burns. 2004 Jun;30(4):305-11
references: 15145186
references: J Clin Oncol. 2005 Feb 1;23(4):792-9
references: 15681523
references: J Clin Oncol. 2008 Apr 20;26(12):2013-9
references: 18421054
references: Nat Med. 1995 Oct;1(10):1024-8
references: 7489357
references: J Clin Oncol. 2009 Aug 10;27(23):3794-801
references: 19564535
references: J Clin Invest. 1999 Jan;103(2):159-65
references: 9916127
references: J Clin Oncol. 2009 Jul 10;27(20):3312-8
references: 19451442
references: J Clin Oncol. 2011 Jun 20;29(18):2557-64
references: 21576632
references: J Natl Cancer Inst. 2005 Jul 6;97(13):981-9
references: 15998951
references: J Clin Oncol. 2012 Aug 10;30(23):2829-36
references: 22753922
references: Am J Physiol Cell Physiol. 2001 Jun;280(6):C1367-74
references: 11350731
references: J Clin Oncol. 2009 May 1;27(13):2231-7
references: 19307500